RxDoctor Payments Data

Nikki Jones, MD

Family Medicine · Bryan, TXNPI 1073072807

Payments from drug & device makers

$1,286in general payments, 2019–2025

Across 73 payments — averaging $17.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$344
  • AstraZeneca$301
  • Novo Nordisk$203
  • Lilly USA, LLC$99
  • Boehringer Ingelheim$72
  • Pfizer$52
  • plus $216 from 8 others

What the payments were for

  • Food & beverage$1,286100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,286 in reported general payments places this provider in the 65th percentile of 8,760 family medicine providers in Texas.

See all family medicine providers in Texas

Medicare billing

Part B allowed, 2024
$53,290
Medicare patients
158
Services billed
538

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide52$73,585
JardianceEmpagliflozin52$41,859
RybelsusSemaglutide18$36,976
XifaxanRifaximin12$35,989
OzempicSemaglutide28$29,756
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$29,337
JanuviaSitagliptin Phosphate24$22,530
FarxigaDapagliflozin Propanediol19$19,310
EliquisApixaban13$16,780
TradjentaLinagliptin13$6,773
Rosuvastatin Calcium279$3,554
Atomoxetine Hcl11$2,501
Levothyroxine Sodium214$2,219
Albuterol Sulfate HfaAlbuterol Sulfate77$1,923
SynthroidLevothyroxine Sodium20$1,341

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$99$73,58552 claims
Novo NordiskRybelsus, Ozempic$203$66,73246 claims
Boehringer IngelheimJardiance, Tradjenta$72$48,63265 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan$31$35,98912 claims
GSKTrelegy Ellipta$24$29,33731 claims
AstraZenecaFarxiga$301$19,31019 claims
PfizerEliquis$52$16,78013 claims
AbbVieSynthroid$344$1,34120 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 8,760 family medicine providers in Texas.

Other family medicine in Bryan

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →